HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$0.34
Day range
$0.31 - $0.39
Year range
$0.22 - $1.53
Market cap
21.12M USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.59M | -30.23% |
Net income | -3.24M | -4.68% |
Net profit margin | — | — |
Earnings per share | -0.03 | 66.67% |
EBITDA | -2.52M | 31.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.89M | -65.01% |
Total assets | 9.62M | -41.51% |
Total liabilities | 3.46M | -74.74% |
Total equity | 6.16M | — |
Shares outstanding | 67.59M | — |
Price to book | 3.78 | — |
Return on assets | -70.52% | — |
Return on capital | -81.94% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.24M | -4.68% |
Cash from operations | -3.16M | -2.93% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 3.19M | -65.81% |
Net change in cash | 27.00K | -99.56% |
Free cash flow | -2.35M | 49.14% |
About
Founded
2021
Headquarters
Website
Employees
15
